Zyprexa® Warning
(800) 889-9248
In 2004 the FDA ordered the pharmaceutical company Eli Lilly to include a Zyprexa® warning about the serious side effect risks associated with this atypical antipsychotic prescription medication. This Zyprexa® warning is the strongest warning that the FDA can order short of pulling a drug off the market. The Zyprexa® warning is required to be located on all patient product packaging information and read aloud in all commercials. The Zyprexa® warning contains information about the risks of diabetes, stroke, and death that are associated with this medication.
Zyprexa® is an atypical antipsychotic that was approved by the FDA in 1996 to treat schizophrenia and bipolar disorder. Zyprexa® is also prescribed "off label" by doctors who feel that this drug's use may prove beneficial to their patients for purposes other than those evaluated and approved by the government regulators. Zyprexa® has been prescribed for other psychological conditions, particularly Alzheimer's and other types of dementia. Eli Lilly estimates that approximately six percent of its Zyprexa® sales go to Alzheimer's and dementia patients.
In 2000 the Australian government issued a Zyprexa® warning after over three hundred adverse Zyprexa® side effects reports were made. In 2001, a Zyprexa® warning was published in the American Medical Association journal stating that Zyprexa® patients were ten times more likely to develop diabetes than the general population. In 2002, both the British and Japanese governments issued Zyprexa® warning statements about the serious diabetes risks posed to Zyprexa® users. While these foreign governments issued Zyprexa® warning statements, the US government remained silent about these risks.
In 2002 Duke University issued a Zyprexa® warning after findings from a large scale study indicated diabetes risks for Zyprexa® patients. Duke, in conjunction with FDA experts, discovered nearly three hundred reports of Zyprexa® users developing diabetes, 71 percent of whom developed this condition only six months after commencing Zyprexa® treatment. Of these patients, one hundred also developed ketosis (a serious complication of diabetes), twenty two developed pancreatitis, and twenty three died from diabetes-related complications.
This Zyprexa® warning prompted American officials to order Eli Lilly to include strong Zyprexa® warning statements on all patient product information. Eli Lilly complied with this request, though they continued to deny that the risks of Zyprexa® use outweighed the intended benefits of this blockbuster drug. The Zyprexa® warning statements have continued since this time. Other reports have indicated that Zyprexa® users are seven times more likely to develop treatment-emergent pancreatitis.
New studies have also found that elderly patients taking Zyprexa® for Alzheimer's and dementia are twice as likely to die or suffer a serious stroke compared to patients in a control group. This Zyprexa® warning has also been added to Zyprexa® labeling. Despite all these Zyprexa® warnings, the pharmaceutical company Eli Lilly still insists their product is safe.
For more information on Zyprexa® warnings, please contact us to speak with a qualified lawyer.
More Zyprexa® News:
January 17, 2007 - Zyprexa® Lawsuit Filed Over Fatal Pancreatitis
December 18, 2006 - New Report Finds Eli Lilly Plays Down Zyprexa® Risks
October 10, 2006 - Zyprexa® Lawsuits Continue To Grow
August 11, 2006 - Zyprexa® Victims To Receive Payout
July 31, 2006 - Mississippi Attorney General Sues Over Zyprexa®
January 10, 2006 - Class action suit filed over Zyprexa®
April 12, 2005 - Elderly patients warned of Zyprexa® risks
April 11, 2005 - Zyprexa® warning issued
February 9, 2005 - Zyprexa®, Zyrtec prescription mix-ups result in hospitalizations
February 5, 2005 - Zyprexa® lawsuit on behalf of Canadians filed
October 25, 2004 - Antipsychotics linked to serious adulthood diseases
May 21, 2004 - Nationwide Zyprexa® class action lawsuit filed
More Zyprexa® Resources:
Zyprexa® Side Effects Lawyer - Provides details on the Zyprexa® bipolar-disorder drug and its side effects, including withdrawal information. Contact an attorney for a consultation.
Zyprexa® - Includes information for patients with schizophrenia.
